Stephens & Co. Maintains Overweight on Tenet Healthcare, Lowers Price Target to $260

Stephens & Co. analyst Raj Kumar maintains Tenet Healthcare (NYSE:THC) with a Overweight and lowers the price target from $275 to $260.